PD-L1 expression in Xp11.2 translocation renal cell carcinoma: Indicator of tumor aggressiveness

Programmed death ligand-1 (PD-L1), a promising antitumor target, has proven clinical value against many malignancies. However, the PD-L1 content of Xp11.2 translocation renal cell carcinoma (Xp11.2 RCC) and its correlation with clinical outcomes remain unclear. This study aimed to investigate PD-L1...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Sci Rep
Hlavní autoři: Chang, Kun, Qu, Yuanyuan, Dai, Bo, Zhao, Jian-Yuan, Gan, Hualei, Shi, Guohai, Zhu, Yiping, Shen, Yijun, Zhu, Yao, Zhang, Hailiang, Ye, Dingwei
Médium: Artigo
Jazyk:Inglês
Vydáno: Nature Publishing Group UK 2017
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5437001/
https://ncbi.nlm.nih.gov/pubmed/28522811
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-017-02005-7
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky